Diabetes & Endocrinology
Conducting clinical trials in the field of Diabetes & Endocrinology presents a myriad of challenges that demand meticulous planning and execution. One significant obstacle lies in patient recruitment and retention, as individuals with these conditions often have complex medical histories and may be hesitant to participate in lengthy trials. Moreover, ensuring compliance with treatment protocols and managing confounding variables such as diet, exercise, and concomitant medications poses a constant challenge. Standardizing outcome measures across diverse patient populations can also be arduous, given the heterogeneous nature of diabetes and endocrine disorders.
Additionally, regulatory requirements and ethical considerations add layers of complexity to trial design and implementation. Despite these hurdles, innovative approaches such as decentralized trials and personalized medicine hold promise for overcoming these challenges and advancing our understanding and treatment of these conditions.
How We Can Help
Our expertise encompasses a range of specialties within Diabetes and Endocrinology, including but not limited to innovative approaches to insulin therapy, novel treatments for hormone imbalances, and groundbreaking research into metabolic disorders. By focusing on these key areas, we aim to continue making strides in the field, ultimately improving the lives of those affected by diabetes and endocrine disorders.
- Type-2 diabetes: Extensive experience in conducting clinical trials for novel medications and treatment strategies aimed at managing Type-2 diabetes, focusing on improving glycemic control and reducing complications.
- Diabetic dyslipidemia: Specialized expertise in investigating the relationship between lipid metabolism and diabetes, with a focus on developing interventions to address dyslipidemia in diabetic patients.
- Wound care: Proven track record in conducting clinical trials to evaluate innovative wound care products and therapies, aimed at accelerating wound healing and reducing the risk of complications in diabetic patients.
- Hyperglycemia: In-depth understanding of the mechanisms underlying hyperglycemia and extensive experience in testing new interventions to effectively manage blood glucose levels in diabetic patients.
- Acromegaly: Specialized knowledge and experience in conducting clinical trials for therapies targeting the underlying causes of acromegaly, focusing on improving symptom management and quality of life for affected individuals.
- Hypothyroidism: Expertise in designing and implementing clinical trials to evaluate the safety and efficacy of treatments for hypothyroidism, with a focus on optimizing thyroid hormone replacement therapy.
- Blood glucose monitoring: Comprehensive understanding of blood glucose monitoring technologies and methodologies, with a focus on validating and improving the accuracy and usability of glucose monitoring devices through rigorous clinical testing.

Our Services
We offer a comprehensive suite of services designed to support every aspect of diabetes and endocrinology research and clinical development. From designing and conducting clinical investigations to managing data, analyzing results, and ensuring regulatory compliance. Our services encompass site feasibilities, investigator selection, patient recruitment strategies, IRB submissions, GCP site audits, medical writing, biostatistics, SAS programming, device vigilance, safety reporting, and regulatory support.
By collaborating with Techsol, you gain access to tailored solutions designed to meet the unique challenges of your therapeutic area. From protocol design to regulatory compliance, our comprehensive services are tailored to support your trial at every stage.
Our approach to conducting diabetes and endocrinology clinical trials is characterized by a patient-centric focus, emphasizing the needs and experiences of patients while minimizing burdensome procedures and fostering clear communication to enhance engagement and retention. We promote multidisciplinary collaboration among healthcare professionals to address the complexity of these conditions comprehensively. Leveraging innovative technologies such as continuous glucose monitoring systems and wearable devices, we collect real-time data and monitor patient progress remotely, improving accuracy and convenience.
Personalized medicine is at the forefront of our trials, tailoring treatment strategies based on individual characteristics and biomarker analysis. Through community engagement and outreach programs, we raise awareness and advocate for preventive measures. Longitudinal follow-up is integral to our trials, allowing us to assess the sustained efficacy and safety of interventions over time, informing long-term management strategies. This holistic approach aims to advance the field, improve patient outcomes, and positively impact the lives of those affected by diabetes and endocrine disorders.
Our Experience
S.No |
Product Details |
Techsol’s Contribution |
|||||
Clinical Operations |
Medical Writing |
Regulatory Affairs |
Statistical & Analysis |
Clinical Data Management |
PV |
||
1 |
Evogliptin |
✔ |
|
|
|
|
|
2 |
Saroglitzar |
|
|
|
|
|
✔ |
3 |
A Study on Control of Diabetes in School and Hostel |
|
✔ |
|
|
|
|
4 |
Metformin |
|
✔ |
|
|
|
|
5 |
Accu check Safe-T-Pro Uno |
|
|
✔ |
✔ |
✔ |
|
6 |
Roche diabetes care platform |
|
|
✔ |
|
✔ |
|
7 |
Accu check my sugar log book |
|
|
✔ |
|
|
|
8 |
Insulin |
✔ |
✔ |
|
✔ |
✔ |
|
9 |
Dapagliflozin 5mg & 10 mg |
|
✔ |
|
|
|
|
10 |
Accu-Chek Active, Accu-Chek Instant, Accu-Chek Instant S |
|
|
✔ |
✔ |
✔ |
|
11 |
Blood Glucose Monitoring test strips and app |
✔ |
|
✔ |
|
|
|
12 |
Linagliptin 5 mg |
|
✔ |
|
|
|
|
13 |
Accu-Chek Softclix Kits (Lancets + Lancing Device) |
✔ |
|
✔ |
|
|
|
14 |
Accu-Chek SugarView Color Card |
✔ |
|
✔ |
|
|
|
15 |
Vildagliptin + Metformin |
|
✔ |
|
|
|
|
16 |
Dapagliflozin+Metformin |
|
✔ |
|
|
|
|
17 |
KAP Survey |
|
✔ |
|
✔ |
✔ |
|
18 |
Beat sugar view(Accu check) |
|
|
|
✔ |
✔ |
✔ |
19 |
Jusline-R |
✔ |
|
✔ |
✔ |
✔ |
✔ |
20 |
Jusline-N |
✔ |
|
✔ |
✔ |
✔ |
✔ |
21 |
Jusline-30/70 |
✔ |
|
✔ |
✔ |
✔ |
✔ |
22 |
Smart Survey |
|
✔ |
|
✔ |
✔ |
|
23 |
OAD Survey |
|
✔ |
|
|
|
|
24 |
MNT & DID Survey |
|
✔ |
|
✔ |
✔ |
|
25 |
GALACTOSEMIA |
|
✔ |
|
|
|
|
26 |
A study on Transient thyro-adrenal failure |
|
✔ |
|
|
|
|
27 |
A study on Hypothyroidism (Q’SHY) |
|
|
|
✔ |
✔ |
✔ |
28 |
Sevelamer Carbonate |
|
|
✔ |
|
|
|
29 |
Lanreotide |
|
|
✔ |
|
|
|